Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection. 2014

Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
Department of Clinical Pharmacology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Japan Department of Pharmacy, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi 371-8511, Japan.

The concentration of darunavir (DRV) in peripheral blood mononuclear cells (PBMCs) was reported to affect the clinical symptoms of patients and the development of drug-resistant viruses. We developed a simple and highly sensitive method to quantify the concentration of DRV in human PBMCs using high-performance liquid chromatography with fluorescence detection. PBMC samples were collected using commercially available tubes for density-gradient centrifugation. To disrupt the cells, we used a heating fragmentation method. To compensate for the disadvantages of the heating fragmentation method, liquid-liquid partitioning was used to destroy the unbroken cells by the degeneration of proteins using an organic solvent. As an analytical column, we used an ODS column. The mobile phase consisted of 20 mmol/L potassium phosphate buffer (pH 4.3)/acetonitrile (57/43, v/v) and was pumped at 1.0 mL/min. The lower limit of quantification was 5 ng/10(6) cells. Good linearity was obtained with 5-100 ng/10(6) cells. The intra- and inter-assay precision and accuracy were <15%. Because our method makes possible the measurement of DRV concentration in PBMCs at medical facilities or laboratories without tandem mass spectrometry systems, we believe that it will contribute to clinical studies and will improve the medical treatment of human immunodeficiency virus infections with DRV.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069454 Darunavir An HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS. Darunavir Ethanolate,Prezista,TMC 114,TMC-114,TMC114,UIC-94017,UIC94017,114, TMC,Ethanolate, Darunavir,UIC 94017
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D057230 Limit of Detection Concentration or quantity that is derived from the smallest measure that can be detected with reasonable certainty for a given analytical procedure. Limits of Detection,Detection Limit,Detection Limits

Related Publications

Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
January 2009, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry,
Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
November 2018, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment,
Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
May 2010, Analytica chimica acta,
Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
September 2013, Journal of food protection,
Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
May 1999, Biomedical chromatography : BMC,
Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
January 2015, Se pu = Chinese journal of chromatography,
Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
January 2000, Journal of AOAC International,
Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
August 2007, Journal of pharmaceutical and biomedical analysis,
Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
December 2023, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Daisuke Nagano, and Takuya Araki, and Tomonori Nakamura, and Koujirou Yamamoto
June 2011, Journal of separation science,
Copied contents to your clipboard!